Clinical Trials Browser

Phase 2 × Hepatitis B × PHY 906 × Clear all

NCT04000737 2025-04-13

YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)

Phase 2 Completed

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular